DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.44 / 10
Underperform
Technically, DRMA scores 1.44/10, classified as poor. The last five days show three bearish indicators: Long Lower Shadow, MACD Death Cross, and Long Upper Shadow, with no bullish signals. Historical win rates for these patterns are below 50%, reinforcing a bearish technical stance.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate40.00%
Hist. Signals80
Avg Return-2.33%
Score1/10
Win Rate40.00%
Hist. Signals80
Avg Return-2.33%
MACD Death Cross
Score2.31/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.30%
Score2.31/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.30%
Long Upper Shadow
Score1/10
Win Rate42.11%
Hist. Signals76
Avg Return-3.79%
Score1/10
Win Rate42.11%
Hist. Signals76
Avg Return-3.79%
Long Lower Shadow
Score1/10
Win Rate40.00%
Hist. Signals80
Avg Return-2.33%
Score1/10
Win Rate40.00%
Hist. Signals80
Avg Return-2.33%
Long Upper Shadow
Score1/10
Win Rate42.11%
Hist. Signals76
Avg Return-3.79%
Score1/10
Win Rate42.11%
Hist. Signals76
Avg Return-3.79%
MACD Death Cross
Score2.31/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.30%
Score2.31/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.30%
What is the current technical signals for DRMA?
- DRMA presents a Underperform setup with a Technical Score of 1.44/10. Key technical indicators highlight an RSI of 42.62 and a MACD of -0.11, with the trend anchored by the 50-Day SMA at 2.38. Traders should monitor key support at 1.69 and resistance at 1.88.
